ArticlemedRxiv : the preprint server for health sciences2025
Diagnosing Sepsis Through Proteomic Insights: Findings from a Prospective ICU Cohort.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Introduction: Sepsis diagnosis remains clinical and heterogeneous. We hypothesized that a proteomics-informed machine-learning approach could identify a small, easy-to-use, and optimized set of clinical variables to complement or potentially outperform SOFA. Methods: We conducted a prospective, single-center, observational study in an academic intensive care unit. Plasma from critically ill patients with and without sepsis was analyzed using liquid chromatography coupled with tandem mass spectrometry (LC-MS). Data were acquired with data-independent acquisition parallel accumulation-serial fragmentation (diaPASEF) and processed using DIA-NN software. Differentially expressed proteins informed model development. Random Forest models were trained in a Discovery cohort (n=55) to select clinical variables linked to the proteome, then tested in an independent Validation cohort (n=59). Recursive feature elimination (RFE) identified a minimal feature set that was predictive of sepsis. The performance was assessed using repeated cross-validation and external validation. Results: Twelve plasma proteins differed between sepsis and non-sepsis patients at FDR < 0.1, corresponding to 26 proteome-enriched clinical variables. The classifier achieved mean AUC's of 0.73 and 0.76 in Discovery and Validation cohorts, respectively. RFE performance plateaued with ≥9 variables, peaked at an accuracy of 0.78, and deteriorated below seven; the final three features before collapse were plasma BUN, chemokine ligand 3 (CCL3), and creatinine. Proteome-to-clinical regression highlighted creatinine as having the strongest correlation (R Discussion: A concise set of routinely obtainable variables anchored by renal markers and CCL3 captured proteomic signals and discriminated sepsis across cohorts, supporting a "proteomics-informed, clinic-first" strategy for pragmatic EHR deployment.While larger multicenter studies are warranted, these findings suggest that renal dysfunction exerts a disproportionate influence on sepsis and that increased emphasis on kidney-related markers may improve both recognition and risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.